- Home
- PGY vs XENE Comparison
PGY vs XENE Comparison
Compare PGY & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGY
- XENE
- Stock Information
- Founded
- PGY 2016
- XENE 1996
- Country
- PGY United States
- XENE Canada
- Employees
- PGY N/A
- XENE N/A
- Industry
- PGY Finance: Consumer Services
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- PGY Finance
- XENE Health Care
- Exchange
- PGY Nasdaq
- XENE Nasdaq
- Market Cap
- PGY 2.6B
- XENE 2.4B
- IPO Year
- PGY N/A
- XENE 2014
- Fundamental
- Price
- PGY $37.26
- XENE $39.21
- Analyst Decision
- PGY Strong Buy
- XENE Strong Buy
- Analyst Count
- PGY 8
- XENE 11
- Target Price
- PGY $37.13
- XENE $52.73
- AVG Volume (30 Days)
- PGY 3.9M
- XENE 833.8K
- Earning Date
- PGY 08-07-2025
- XENE 08-11-2025
- Dividend Yield
- PGY N/A
- XENE N/A
- EPS Growth
- PGY N/A
- XENE N/A
- EPS
- PGY N/A
- XENE N/A
- Revenue
- PGY $1,153,015,000.00
- XENE $7,500,000.00
- Revenue This Year
- PGY $27.97
- XENE N/A
- Revenue Next Year
- PGY $16.50
- XENE $256.34
- P/E Ratio
- PGY N/A
- XENE N/A
- Revenue Growth
- PGY 24.59
- XENE N/A
- 52 Week Low
- PGY $8.20
- XENE $26.74
- 52 Week High
- PGY $41.48
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- PGY 63.91
- XENE 67.80
- Support Level
- PGY $34.76
- XENE $38.13
- Resistance Level
- PGY $38.86
- XENE $39.84
- Average True Range (ATR)
- PGY 2.56
- XENE 0.99
- MACD
- PGY 0.14
- XENE -0.09
- Stochastic Oscillator
- PGY 78.86
- XENE 77.70
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.